Vasorelaxation to the HNO donor isopropylamine NONOate in resistance arteries does not require perivascular CGRP
HNO donors offer considerable therapeutic potential for the treatment of hypertension-related cardiovascular disorders, particularly heart failure, as they combine an inotropic action with peripheral vasodilation. Angeli’s salt (AS) is the only HNO donor whose mechanism has been studied in depth, an...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Published: |
American Heart Association
2017
|